Tung-Chung Mou (Tung Chung Mou)

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 3

Top Topics

Pluripotent Stem Cells

Crystal Structure

Metastatic Colorectal Cancer

Top Venues

Acta crystallographica. Section F, Structural biology communications

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Stephanie M Bester, Rebecca Linwood, Ryoko Kataoka, Wen-I Wu, Tung-Chung Mou
Enhancing the apo protein tyrosine phosphatase non-receptor type 2 crystal soaking strategy through inhibitor-accessible binding sites. Acta crystallographica. Section F, Structural biology communications (2024)
Stephanie M Bester, Rebecca Abrahamsen, Luiza Rodrigues Samora, Wen-I Wu, Tung-Chung Mou
Crystal structure of the GDP-bound human M-RAS protein in two crystal forms. Acta crystallographica. Section F, Structural biology communications (2024)
Rona Yaeger, Meredith A McKean, Rizwan Haq, J Thaddeus Beck, Matthew H Taylor, Jonathan Eliezer Cohen, Daniel W Bowles, Shirish M Gadgeel, Catalin Mihalcioiu, Kyriakos P Papadopoulos, Eli L Diamond, Keren B Sturtz, Gang Feng, Stefanie K Drescher, Micaela B Reddy, Bhaswati Sengupta, Arnab Kumar Maity, Suzy A Brown, Anurag Singh, Eric N Brown, Brian R Baer, Jim Wong, Tung-Chung Mou, Wen-I Wu, Dean R Kahn, Sunyana Gadal, Neal X Rosen, John J Gaudino, Patrice A Lee, Dylan P Hartley, S Michael Rothenberg
A next-generation BRAF inhibitor overcomes resistance to BRAF inhibition in patients with BRAF-mutant cancers using pharmacokinetics-informed dose escalation. Cancer discovery (2024)